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The impact of obesity as a systemic low-grade inﬂammatory process has only partially been explored. To this eﬀect, 704
community-basedschool-agedchildren(354obesechildrenand350age-,gender-,andethnicity-matchedcontrols)wererecruited
and underwent assessment of plasma levels of fasting insulin and glucose, lipids, and a variety of proinﬂammatory mediators that
are associated with cardiometabolic dysfunction. Obese children were at higher risk for abnormal HOMA and cholesterol levels.
Furthermore, BMI z score, HOMA, and LDL/HDL ratio strongly correlated with levels of certain inﬂammatory mediators. Taken
together, obesity in children is not only associated with insulin resistance and hyperlipidemia, but is accompanied by increased,
yet variable, expression of markers of systemic inﬂammation. Future community-based intervention and phenotype correlational
studies on childhood obesity will require inclusion of expanded panels of inﬂammatory biomarkers to provide a comprehensive
assessment of risk on speciﬁc obesity-related morbidities.
1.Introduction
Childhood obesity is a serious and progressively increasing
public health problem that has reached epidemic propor-
tions and in the United States disproportionately aﬀects
low-income and minority children [1–3]. Metabolic and
cardiovascular complications of obesity in childhood, while
less common than in adulthood, may nevertheless include
insulin resistance and type 2 diabetes. Body mass index
(BMI) tracks from childhood to adulthood and as such,
overweight and obese children are at greater risk of devel-
oping not only hypertension, metabolic, and cardiovascular
diseases, but also asthma and sleep apnea in later life [4–8].
In adults, obesity is associated with increases in systemic
inﬂammatory markers, as evidenced by studies documenting
the association of BMI and visceral obesity with circulating
levels of cytokines and acute-phase reactants [9–11]. In
children,thepresenceofobesity alsoappearstobeassociated
with increased levels of high-sensitivity CRP (hsCRP) [12],
as well as other inﬂammatory mediators [13–17], that pro-
motethedevelopmentofendothelialandmetabolicdysfunc-
tion [18–21]. A recent review on this topic [22]c o n c l u d e d
that although there appears to be suﬃcient evidence to
support the existence of an association between obesity and
increased hsCRP along with decreased adiponectin levels,
the circulating levels found in the majority of the studies
published in the literature are generally within the normative
range, and could therefore underestimate the concentrations
of these mediators at the tissue level. Tam et al. further
recommended additional studies measuring IL-6 and TNF-
α, as well as other interleukins and chemokines in young
children [22].
Concurrent with such understanding of the published
literature and in agreement with the recommendations by
Tam and colleagues [22], we hypothesized that by examining
the concentration of fasting morning plasma inﬂammatory2 International Journal of Pediatrics
mediators obtained from community-based obese children,
we would expect to ﬁnd variable expression of speciﬁc
inﬂammatory mediators in this cohort that have previously
been shown to increase the cardiovascular and/or metabolic
disease risk.
2. Methods
2.1. Subjects. The study was approved by the University
of Louisville Human Research Committee, and informed
consent was obtained from the legal caregiver of each
participant. Consecutive children between the ages of 5
to 8 years attending public schools in Jeﬀerson County,
Louisville, KY, were invited to participate in the study,
after they underwent a school-based health screening, which
included height and weight measurements. Based on such
screening, children were identiﬁed when their BMI z score
was ≥1.65andage-(within3–6months),gender-,ethnicity-,
and area-of-residence-matched children with BMI z scores
<1.65 were then identiﬁed and recruited to serve as controls.
Of note, all children were otherwise healthy, were recruited
from the community via the Jeﬀerson County Public School
Health Screening Program, and were representative of the
demographic characteristics of the general population of the
city of Louisville (http://ksdc.louisville.edu/sdc/census2000/
cityproﬁles/LouisvilleDP.pdf).Childrenwereexcludedifthey
had known diabetes or prediabetes (http://www.diabetes
.org/pre-diabetes/pre-diabetes-symptoms.jsp), any deﬁned
geneticabnormalityorunderlyingsystemicdiseaseincluding
hypertension (as deﬁned by a systolic or diastolic blood
pressure exceeding the 95th percentile for age, gender, and
height using population data obtained by the National Heart
Lung and Blood Institute), or if they were within a month
from any acute infectious process.
2.2. Anthropometry. To verify the school-health screening
initial reports, children were weighed using a calibrated scale
to the nearest 0.1kg and height (to 0.1cm) was measured
with a stadiometer (Holtain, Crymych, UK). Body mass in-
dex (BMI) was calculated and BMI z-score was computed
using CDC 2000 growth standards (http://www.cdc.gov/
growthcharts/) and online software (http://www.cdc.gov/
epiinfo/). A BMI z score ≥1.65 was considered as fulﬁlling
the criteria for obesity.
2.3. Blood Based Assays. Fasting blood samples were drawn
by venipuncture in the morning. Blood samples were
immediately centrifuged, and plasma was frozen at −80◦C
until assay. Plasma insulin levels were measured using
a commercially available radioimmunoassay kit (Coat-A-
Count Insulin; Diagnostic Products Inc). This method has a
detection level of 1.2μIU/mL and exhibits linear behavior up
to 350μIU/mL, with intra-assay and interassay coeﬃcients
of variability of 3.1% and 4.9%, respectively. Plasma glu-
cose level was measured using a commercial kit based on
the hexokinase-glucose-6-phosphate dehydrogenase method
(Flex Reagent Cartridges; Dade Behring, Newark, DE).
Insulin resistance was assessed using a widely validated
mathematical formula, the homeostasis model assessment
(HOMA) equation (fasting insulin × fasting glucose/22.5)
[23].
Plasma hsCRP levels were measured within 2-3 hours
after collection using the Flex Reagent Cartridge (Date
Behring, Newark, DE). This method has a detection level of
0.05mg/dL and exhibits linear behavior up to 255mg/dL,
with intra-assay and interassay coeﬃcients of variability
of 9% and 18%, respectively, for hsCRP. Serum lipids
including total cholesterol, high-density lipoprotein (HDL)
cholesterol, calculated low-density lipoprotein cholesterol
(LDL), and triglycerides (TG) were also assessed using Flex
Reagent Cartridges (Dade Behring).
Plasma IL-6, IL-20, monocyte chemotactic protein
(MCP), retinol-binding protein 4 (RBP4), and tumor necro-
sis factor (TNF-α) levels were measured using commer-
cial ELISA kits (R&D systems, Minneapolis, MN). Plasma
apolipoprotein B (ApoB), myeloid-related protein (MRP)
8/14, and macrophage inhibitory factor (MIF) levels were
also measured using commercial ELISA kits (ALPCO Diag-
nostics, Salem, NH) following the manufacturer’s instruc-
tions. Circulating levels of ICAM-1 and P-selectin were
measured with commercially available kits (R&D System,
Abington, UK). For ICAM-1, the sensitivity was 0.35ng/mL
and the intra- and interassay coeﬃcients of variation were
2.5 and 1.8%, respectively. For P-selectin, the sensitivity
was 0.5ng/mL and the intra- and interassay coeﬃcients of
variation were 3.6 and 6.9%, respectively. All assays were
performed in duplicate, and a calibration curve was included
in each assay.
2.4. Statistical Analysis. Data were expressed as mean ± SD.
Signiﬁcant diﬀerences within groups were analyzed using
ANOVA followed by post-hoc tests with Bonferroni cor-
rections for multiple comparisons for continuous variables
and chi-square tests for categorical variables. Spearman’s
correlation analyses were conducted to examine potential
associations between BMI and plasma concentrations of
the various inﬂammatory mediators. Statistical analyses
were performed using SPSS software (version 16.0; SPPS
Inc., Chicago, Ill.). All P values reported are 2-tailed with
statistical signiﬁcance set at <.05.
3. Results
A total of 354 obese children and 350 age-, gender-,
and ethnicity-matched nonobese children were recruited
between May 2004 and October 2008. The demographic
characteristics of this cohort are shown in Table 1 and are
virtually identical to the published demographics of the
city of Louisville, Kentucky. It should be pointed out that
not every child could have all of the inﬂammatory markers
assayed, as dictated by the limited amounts of plasma, such
that, the number of inﬂammatory marker assays varied from
one child to another.
As anticipated, obese children had higher HOMA values,
indicative of insulin resistance, and also exhibited higher
LDL, VLDL, and TG levels and lower HDL concentrations
compared to nonobese children (Table 1).International Journal of Pediatrics 3
Table 1: Demographic characteristics of obese and nonobese
children.
Obese
(BMI Z ≥ 1.65)
Nonobese
(BMI Z<1.65)
P-value∗
Age (years) 7.1 ±0.4
(n = 354)
7.1 ±0.4
(n = 350)
Gender
(% male) 51.2 51.1
Ethnicity
White
Caucasian % (n)
77.9
(n = 277)
78.0
(n = 273)
African-
American %
(n)
18.1
(n = 64)
18.0
(n = 63)
BMI z score 2.21 ±0.14 1.06 ±0.21 <.00001
Systolic Blood
Pressure
(mmHg)
112.4 ±9.7
(n = 354)
107.1 ±10.9
(n = 350)
<.01
Diastolic blood
pressure
(mmHg)
67.1 ±8.2
(n = 354)
62.7 ±7.9
(n = 350)
<.01
Triglycerides 84.1 ±5.17 3 .5 ±2.8 <.001
HDL 42.5 ±1.86 2 .9 ±1.8 <.00001
VLDL 19.1 ±1.31 4 .7 ±0.9 <.001
LDL 98.7 ±2.99 3 .3 ±1.8 <.001
Glucose 81.3 ±1.87 8 .2 ±1.7 <.04
Insulin 14.9 ±1.76 .7 ±1.0 <.0001
HOMA-IR 2.3 ±0.31 .2 ±0.3 <.0001
∗Statistical signiﬁcance determined using ANOVA test.
Obese children also had signiﬁcantly higher levels of
hsCRP, IL-6, MRP 8/14, P-selectin, ICAM-1, IL-20, RBP4,
MIF, and TNF-α compared to nonobese children (Table 2).
Only ApoB and MCP showed similar levels among the 2
groups. Among the obese children, 57% showed one, 34%
two, 19% three, and 15% four or more cardiometabolic
biomarkers with elevated plasma levels.
Regression analyses between each of the inﬂammatory
markers and actual BMI or BMI z score revealed signiﬁcant
correlations for the majority of these markers (Table 3). In
addition, hsCRP was also signiﬁcantly associated with IL-6
(r = 0.35; n = 145; P<. 01), MRP 8/14 (r = 0.67; n =
236; P<. 001), and with TNF-α (r = 0.46; n = 122; P<
.01). Furthermore, hsCRP was also positively correlated with
ICAM-1 (r = 0.29; n = 98; P<. 03) and with RBP4 (r =
0.32; n = 80; P<. 05). Similarly, signiﬁcant correlations
emerged between RBP4, MRP 8/14, TNF-α, hsCRP, and
HOMA (Table 3). In addition MRP 8/14, IL-6, hsCRP, MIF,
P-selectin, ICAM-1, and TNF-α levels showed signiﬁcant
associations with LDL/HDL (Table 3).
4. Discussion
This study shows that systemic inﬂammatory processes are
activated in otherwise asymptomatic, community-dwelling,
obese,andschool-ageprepubertalchildren.Interestingly,the
Table 2: Fasting morning plasma concentrations of inﬂammatory
biomarkers in obese and nonobese children.
Obese
(BMI Z ≥ 1.65)
Nonobese
(BMI Z<1.65)
P-values∗
MRP 8/14
(ug/mL)
1.5 ±0.9
(n = 128)
0.9 ±0.8
(n = 176)
.0001
Apo B
(mg/dL)
77.8 ±19.6
(n = 65)
73.7 ±16.3
(n = 51)
.233
MCP
(pg/mL)
132.0 ±29.6
(n = 77)
120.1 ±18.8
(n = 68)
.494
RBP4
(ng/mL)
33.4 ±16.3
(n = 80)
18.2 ±14.0
(n = 80)
.01
IL-20
(pg/mL)
4.0 ±5.4
(n = 67)
2.3 ±4.5
(n = 44)
.02
IL-6 (pg/mL) 1.8 ±0.9
(n = 132)
1.0 ±0.6
(n = 134)
.01
MIF
(pg/mL)
188.6 ±103.1
(n = 132)
131.7 ±86.4
(n = 106)
.02
hsCRP
(mg/dL)
2.3 ±1.4
(n = 354)
0.5 ±0.3
(n = 350)
<.0001
TNF-α
(pg/mL)
598.5 ± 62.2
(n = 172)
317.3 ± 42.2
(n = 176)
.0001
P selectin
(ng/mL)
94.3 ± 22.2
(n = 56)
37.7 ± 12.9
(n = 90)
.0001
ICAM-1
(ng/mL)
397.4 ±83.5
(n = 56)
247.4 ±53.5
(n = 90)
.0001
∗Statistical signiﬁcance determined using ANOVA test.
degree and nature of the activation of these inﬂammatory
processes varied from child to child, and only a minority
of obese children exhibited extensive derangements across
multiple cardiometabolic inﬂammatory biomarkers. Fur-
thermore, there were signiﬁcant associations between spe-
ciﬁc subsets of the inﬂammatory markers and the degree of
obesity,insulinresistance,orhyperlipidemia.However,while
there was some degree of overlap among the inﬂammatory
markers associated with each of these variables, the more
remarkable ﬁnding was that even if a particular marker was
elevated and correlated with end-organ dysfunction, this did
not necessarily imply that all other markers were aﬀected
as well. The pathophysiology of end-organ morbidities that
are traditionally perceived as resulting from the long-term
eﬀects of obesity on health has been postulated to involve
low-grade activation of multiple pathways of inﬂammation.
Based on the current understanding of the roles played
by these inﬂammatory mediators, it becomes imperative
to explore the role of genetic, environmental, and lifestyle
inﬂuences on the modulation of the inﬂammatory responses
in the context of obesity, and its consequences [24, 25].
Similarly, it will be critical to assess in the future the eﬀect
of interventions such as dietary changes and physical activity
on the reversibility of these inﬂammatory responses and on
the progression of obesity-related morbidities [26–30].
Before we discuss any further the potential implica-
tions of our ﬁndings, some technical and methodological
approaches deserve comment. We selected a wide net array
of known biomarkers for both cardiovascular and metabolic4 International Journal of Pediatrics
Table 3:Correlationcoeﬃcients betweenBMIandBMIz scoreand
plasma levels of several inﬂammatory markers in children.
BMI BMI z score HOMA LDL/HDL ratio
r-value r-value r-value r-value
MRP 8/14 (ug/mL)
(n = 249)
0.354∗ 0.375∗ 0.332∗ 0.227∗
Apo B (mg/dL)
(n = 116)
0.143 0.160 0.02 0.10
MCP (pg/mL)
(n = 143)
0.00 0.00 0.00 0.12
RBP4 (ng/mL)
(n = 160)
0.213∗ 0.317∗ 0.376∗ 0.09
IL-20 (pg/mL)
(n = 111)
−0.054 −0.036 0.01 0.03
IL-6 (pg/mL)
(n = 266)
0.161∗ 0.177∗ 0.132∗ 0.134∗
MIF (pg/mL)
(n = 108)
0.043 0.02 0.110∗ 0.176∗
hsCRP (mg/dL)
(n = 704)
0.472∗ 0.367∗ 0.276∗ 0.365∗
TNF-α (pg/mL)
(n = 348)
0.298∗ 0.336∗ 0.187∗ 0.215∗
P selectin (ng/mL)
(n = 146)
0.310∗ 0.376∗ 0.087 0.387∗
ICAM-1 (ng/mL)
(n = 146)
0.254∗ 0.276∗ 0.104 0.413∗
In parenthesis in the number of observations for which data were available,
∗P<. 05. Statistical signiﬁcance determined using Spearman’s correlational
analysis.
dysfunction, in an attempt to characterize the variability and
the potential associations of these markers in the context of
pediatric obesity. However, since hsCRP has been extensively
used in past studies, we aimed to include this measure
in all children. We also restricted the age range of our
cohort to a narrow time span that is associated with the
initial 3 years of attendance in the public school system, a
period during which changes in eating patterns are now well
described [31–34]. We also selected our population based on
a representative community sample for the city of Louisville,
Kentucky, and identiﬁed this cohort in the school system
itself, rather than using a clinical referral cohort. As such, we
also selected a closely matching nonobese child, in the same
school, to control for and all of the potential confounders
that could be introduced in the process of cohort allocation.
However, neither pubertal status nor the presence of hepatic
steatosis was assessed.
Globally, the ﬁndings from this study indicate the
presence of a substantial inﬂammatory burden in obese
prepubertal children along with a high risk for insulin
resistance and increased serum lipids. Therefore, our study
is in close agreement with multiple other studies in children
that have examined a selected number of inﬂammatory
mediators in the context of obesity [12, 35–46]. Of note,
in a study by Nagel and colleagues, these investigators did
not ﬁnd any evidence for a signiﬁcant association between
increased body weight in children and ApoB levels, and our
current ﬁndings are in close concordance with such report
in German children [44]. Similarly, our ﬁndings concur with
the increased plasma levels of adhesion molecules in a pedi-
atric overweight cohort from Mexico, suggesting evidence of
endothelial dysfunction in a substantial proportion of obese
children [47]. Of note, the inﬂammatory markers that were
presently associated with either BMI, BMI z score, HOMA,
and hypercholesterolemia varied, suggesting diﬀerent and
coordinated biological roles for clusters of inﬂammatory
modulators.Indeed,althoughtherewassomedegreeofover-
lap among the inﬂammatory markers and their respective
signiﬁcant associations, only a portion of the markers were
correlated with any given end-organ dysfunction.
In summary, this study clearly shows that obesity in
childhood carries a substantial inﬂammatory burden that is
strongly, yet selectively, associated with speciﬁc functional
alterations, such as insulin sensitivity or lipid homeostasis.
With the emergence of multiplexed ELISA assays that
exhibit improved sensitivities, we would advocate that future
community-based intervention or correlational studies on
childhoodobesity[48]shouldexploremoreexpansivepanels
of inﬂammatory markers along with functional phenotypes,
and should also consider incorporation of genomic vari-
ance assessments using recently developed cardiovascular or
metabolic gene-centric polymorphism arrays [49].
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